This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3lok
From Proteopedia
Drug resistant cSrc kinase domain in complex with covalent inhibitor PD168393
Template:ABSTRACT PUBMED 21080395
About this Structure
3LOK is a 2 chains structure with sequences from Gallus gallus. Full crystallographic information is available from OCA.
Reference
- Kluter S, Simard JR, Rode HB, Grutter C, Pawar V, Raaijmakers HC, Barf TA, Rabiller M, van Otterlo WA, Rauh D. Characterization of irreversible kinase inhibitors by directly detecting covalent bond formation: a tool for dissecting kinase drug resistance. Chembiochem. 2010 Dec 10;11(18):2557-66. PMID:21080395 doi:10.1002/cbic.201000352
Page seeded by OCA on Wed Dec 22 09:53:27 2010
Categories: Gallus gallus | Non-specific protein-tyrosine kinase | Gruetter, C. | Rauh, D. | Rode, H B. | Atp-binding | Covalent inhibitor | Drug resistance | Irreversible inhibitor | Kinase | Lipoprotein | Myristate | Nucleotide-binding | Pd168393 | Phosphoprotein | Proto-oncogene | Sh2 domain | Sh3 domain | Src kinase domain | Transferase-transferase inhibitor complex | Tyrosine-protein kinase
